- Home
- CAN vs BME Comparison
CAN vs BME Comparison
Compare CAN & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAN | BME |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Trusts Except Educational Religious and Charitable |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.0M | 547.5M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CAN | BME |
|---|---|---|
| Price | $0.50 | $41.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $3.09 | N/A |
| AVG Volume (30 Days) | ★ 12.1M | 34.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $63.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $34.18 |
| 52 Week High | $2.22 | $42.74 |
Technical Indicators
Market Signals| Indicator | CAN | BME |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 35.16 |
| Support Level | $0.43 | $40.55 |
| Resistance Level | $0.80 | $42.55 |
| Average True Range (ATR) | 0.04 | 0.55 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 47.27 | 16.34 |
Price Performance
Historical ComparisonAbout CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.